Rompag 50 mg Tablets

Rompag 50 Mg Tablets

*To be consumed as directed by physician.

Therapies:

Supportive

Composition:

Eltrombopag 50 mg

About Rompag 50 Mg Tablets

Rompag 50 mg Tablets contains Eltrombopag 50 mg, a thrombopoietin receptor agonist used to increase platelet production in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP), thrombocytopenia associated with chronic hepatitis C virus (HCV) infection, and severe aplastic anemia. It works by stimulating the bone marrow to produce more platelets, thereby helping reduce the risk of bleeding. Rompag 50 mg Tablets should be used only under the supervision of a qualified healthcare professional, with regular monitoring of platelet counts and liver function.

Rompag 50 Mg Tablets

*To be consumed as directed by physician.


Usage Instructions

  • Take Rompag 50 mg Tablets exactly as prescribed by your doctor.
  • It should be taken on an empty stomach, either 1 hour before or 2 hours after meals.
  • Swallow the tablet whole with water.
  • Avoid taking it with dairy products, calcium-fortified juices, antacids, or mineral supplements containing calcium, iron, magnesium, aluminum, selenium, or zinc.
  • Take the medicine at least 2 hours before or 4 hours after consuming these products.
  • Continue treatment for the full duration advised by your doctor, and attend all scheduled blood tests and follow-up appointments.

  • Benefits and Use

  • Rompag 50 mg Tablets is used to increase platelet counts in patients with chronic immune thrombocytopenia (ITP) who have not responded adequately to other treatments, helping reduce the risk of bruising and bleeding.
  • It is also used to treat low platelet counts associated with chronic hepatitis C infection, enabling patients to receive antiviral therapy when appropriate.
  • In addition, it is used in combination with other medicines for the treatment of severe aplastic anemia, where it helps stimulate the production of blood cells and improves bone marrow function.

  • Safety Information

  • Use only under medical supervision.
  • Regular monitoring of platelet counts, liver function tests, and complete blood counts is essential during treatment.
  • Pregnancy: Use during pregnancy only if clearly recommended by your doctor, as potential risks to the unborn baby may exist.
  • Breastfeeding: Not recommended during breastfeeding, as the medicine may pass into breast milk and could harm the infant.
  • Liver Disease: Patients with liver disease may require dose adjustments and close monitoring.
  • Kidney Disease: Use with caution in patients with kidney impairment and follow your doctor's advice.
  • Food & Drug Interactions: Avoid taking Rompag together with dairy products, calcium-fortified beverages, antacids, or supplements containing calcium, iron, magnesium, aluminum, selenium, or zinc, as they reduce the absorption of the medicine.
  • Common Side Effects: Nausea, vomiting, diarrhea, muscle pain, increased liver enzymes, upper respiratory tract infections, and urinary tract infections.
  • Seek Immediate Medical Attention if you develop signs of severe allergic reactions, yellowing of the skin or eyes, severe abdominal pain, unusual swelling, chest pain, difficulty breathing, sudden weakness, vision changes, or unusual bleeding or bruising.
  • Inform your doctor about all medicines you are taking and any history of liver disease, blood clotting disorders, or other serious medical conditions before starting treatment.

  • Ingredients

    Eltrombopag 50 mg

    How to Use

  • Swallow the tablet whole with a glass of water.
  • Do not crush, chew, or break the tablet.
  • Take it at the same time each day on an empty stomach.
  • Maintain the recommended interval between Rompag and calcium-containing foods, dairy products, antacids, or mineral supplements to ensure proper absorption.
  • Do not change the dose or stop treatment without consulting your doctor.

  • Storage Information

    Store below 30°C in a cool, dry place, away from direct sunlight, heat, and moisture.